← Back to Clinical Trials
Recruiting NCT07238933

NCT07238933 Neurological Events and Unforeseen Risks After Locoregional-anesthesia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07238933
Status Recruiting
Phase
Sponsor Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva
Condition Regional Anesthesia
Study Type OBSERVATIONAL
Enrollment 3,396 participants
Start Date 2026-02-18
Primary Completion 2027-01-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Observational assessment after regional anesthesia

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 3,396 participants in total. It began in 2026-02-18 with a primary completion date of 2027-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a multicenter, prospective, observational study aimed at determining the incidence of neurological and non-neurological complications following locoregional anesthesia procedures. The study will collect data on events such as nerve injury, hematoma, pneumothorax, and local anesthetic systemic toxicity.

Eligibility Criteria

Inclusion Criteria: * Age ≥ 18 years. * Scheduled to undergo a single-shot nerve or fascial plane block. * Ability to provide written informed consent. Exclusion Criteria: * Performance of more than one single-shot nerve or fascial plane block within the same anatomical region or sensory distribution during the same procedure. * Use of continuous nerve or fascial plane catheter-based anesthesia. * Presence of a language barrier that, in the investigator's judgment, would prevent adequate follow-up.

Contact & Investigator

Central Contact

Cristina Cacciagrano Clinical Reasearch Office SIAARTI

✉ ricerca@siaarti.it

📞 +39 06 4452816

Principal Investigator

Alessandro De Cassai Prof., MD

PRINCIPAL INVESTIGATOR

UOC Istituto di Anestesia e Rianimazione, Azienda Ospedale Università di Padova

Frequently Asked Questions

Who can join the NCT07238933 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Regional Anesthesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07238933 currently recruiting?

Yes, NCT07238933 is actively recruiting participants. Contact the research team at ricerca@siaarti.it for enrollment information.

Where is the NCT07238933 trial being conducted?

This trial is being conducted at Bergamo, Italy, Brescia, Italy, Rozzano, Italy, Padova, Italy.

Who is sponsoring the NCT07238933 clinical trial?

NCT07238933 is sponsored by Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva. The principal investigator is Alessandro De Cassai Prof., MD at UOC Istituto di Anestesia e Rianimazione, Azienda Ospedale Università di Padova. The trial plans to enroll 3,396 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology